Grigg A - Search Results

1

Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation.

Grigg A, Kannan K, Schwarer AP, Spencer A, Szer J. Grigg A, et al. Intern Med J. 2001 Jan-Feb;31(1):15-22. doi: 10.1046/j.1445-5994.2001.00013.x. Intern Med J. 2001. PMID: 11478351 Clinical Trial.

2

Successful donor leukocyte infusion for chronic myeloid leukemia relapsing in accelerated phase after T cell-replete unrelated marrow transplantation.

Grigg A, Szer J. Grigg A, et al. Bone Marrow Transplant. 1996 Sep;18(3):647-8. Bone Marrow Transplant. 1996. PMID: 8879633

3

G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis.

Grigg A, Vecchi L, Bardy P, Szer J. Grigg A, et al. Aust N Z J Med. 1996 Dec;26(6):813-8. doi: 10.1111/j.1445-5994.1996.tb00630.x. Aust N Z J Med. 1996. PMID: 9028513

4

Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants.

Abraham R, Szer J, Bardy P, Grigg A. Abraham R, et al. Among authors: grigg a. Bone Marrow Transplant. 1997 Nov;20(9):773-7. doi: 10.1038/sj.bmt.1700961. Bone Marrow Transplant. 1997. PMID: 9384480 Clinical Trial.

5

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma.

Grigg A, Bardy P, Byron K, Seymour JF, Szer J. Grigg A, et al. Bone Marrow Transplant. 1999 Jan;23(2):107-10. doi: 10.1038/sj.bmt.1701540. Bone Marrow Transplant. 1999. PMID: 10197793

6

Mini-allografts' for haematological malignancies: an alternative to conventional myeloablative marrow transplantation.

Grigg A, Seymour JF, Roberts A, Szer J. Grigg A, et al. Aust N Z J Med. 1999 Jun;29(3):308-14. doi: 10.1111/j.1445-5994.1999.tb00711.x. Aust N Z J Med. 1999. PMID: 10868492

7

Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy.

Chong G, Byrnes G, Szer J, Grigg A. Chong G, et al. Among authors: grigg a. Bone Marrow Transplant. 2000 Nov;26(9):1011-5. doi: 10.1038/sj.bmt.1702659. Bone Marrow Transplant. 2000. PMID: 11100282 Review.

8

Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosis.

Grigg A, Tubridy NJ, Szer J, Mitchell P, Butzkueven H, Shuttleworth P, Kilpatrick T. Grigg A, et al. Intern Med J. 2004 Jan-Feb;34(1-2):66-9. doi: 10.1111/j.1444-0903.2004.00516.x. Intern Med J. 2004. PMID: 14748917

9

Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan.

Ritchie DS, Morton J, Szer J, Roberts AW, Durrant S, Shuttleworth P, Grigg AP. Ritchie DS, et al. Biol Blood Marrow Transplant. 2003 Jul;9(7):435-42. doi: 10.1016/s1083-8791(03)00128-9. Biol Blood Marrow Transplant. 2003. PMID: 12869957 Free article. Clinical Trial.

10

Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma.

Grigg AP, Stone J, Milner AD, Schwarer AP, Wolf M, Prince HM, Seymour J, Gill D, Ellis D, Bashford J; Australasian Leukaemia & Lymphoma Group. Grigg AP, et al. Leuk Lymphoma. 2010 Apr;51(4):641-9. doi: 10.3109/10428191003611428. Leuk Lymphoma. 2010. PMID: 20218809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters